Jonathan Yewdell

33PUBLICATIONS
234CO-AUTHORS
GlycoconjugatesBiomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)Genomics and transcriptomicsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Jul 20, 2026
Viral syncytia evolve to resist interferon.

|Jan 20, 2026
MHC one-two punch knocks out cancer.

Amir Ghorbani, Jonathan W Yewdell

|Sep 18, 2025
Nanoscopy Reveals Heparan Sulfate Clusters as Docking Sites for SARS-CoV-2 Attachment and Entry.

Sue Han, Xin Wang, Tiansheng Li

|Aug 20, 2025
High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies.

Victoria Callahan, Matthew S Sutton, Christina L Gardner

Pageof 6